Search results
FDA Approves Biosimilars for Macular Degeneration Treatment
Healthline via AOL· 3 days agoThe FDA approved two interchangeable biosimilars to treat macular degeneration. The biosimilars work...
FDA grants approval for two Eylea biosimilars for eye conditions
Pharmaceutical Technology via Yahoo Finance· 5 days agoThe US Food and Drug Administration (FDA) has approved Yesafili (aflibercept-jbvf) and Opuviz (...
Biocon Biologics Obtains U.S. FDA Approval for Biosimilar Aflibercept for Yesafili™. Enters U.S....
WTRF Wheeling· 5 days agoFood and Drug Administration (US FDA) has approved the Company's first-to-file application for Yesafili™ (aflibercept-jbvf), an interchangeable* biosimilar aflibercept ...
Biocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Investing.com· 5 days agoBiocon Biologics gets US FDA nod for biosimilar version of eye treatment drug Eylea
Kodiak Sciences Announces Treatment of First Patients in Phase 3 GLOW2 Study of Tarcocimab Tedromer...
WTNH-TV New Haven· 2 weeks agoGLOW2 is the second Phase 3 study of tarcocimab in diabetic retinopathy in which all patients on...